The rise of Viagra initially drove a period of growth for major pharmaceutical companies, however recent developments present a murky scenario for shareholders. Off-patent versions are reducing revenue, and ongoing https://deannabbyx127879.blogacep.com/46804022/sildenafil-and-big-pharma-a-risky-investment